Novartis Investigative Site

Ahlen 59229

0 studies enrolling now · 2 studies all time

What they study most

Asthma, Heart Failure With Reduced Ejection Fraction (HF-rEF)

Studies at this site

• Multiple Patient Program to Ensure Access to LCZ696 Treatment to Patients Diagnosed With Heart Failure With Reduced Ejection Fraction (HF-rEF) — NO_LONGER_AVAILABLE
• A Multicenter Randomized 52 Week Treatment Double-blind, Triple Dummy Parallel Group Study to Assess the Efficacy and Safety of QMF149 Compared to Mometasone Furoate in Participants With Asthma — Completed